EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Robust CD8 T-cell response generated via attenuated Plasmodium sporozoite prime and multi-epitope mRNA vaccine boost

Sahaana Arumugam, Mariah Hassert, Blandine Franke-Fayard, John T Harty

The Journal of Immunology · 02.11.2026 · 215 (11)

DOI: 10.1093/jimmun/vkag314 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 17.11.2026. Verfasst von Sahaana Arumugam und 3 weiteren Autor:innen. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plasmodium infections and subsequent malaria disease remain a global health scourge. Liver-resident and circulating memory CD8 T cells elicited by whole parasite vaccines such as genetically or radiation-attenuated sporozoites can provide potent immunity to Plasmodium infection and prevent the development of the symptomatic blood stage of infection in humans, nonhuman primates, and mice. However, this requires multiple, large doses of attenuated sporozoites, posing numerous logistical challenges. To partially address these logistical challenges, here, we prime CB6F1 mice with a human weight–normalized, subprotective single dose of genetically or radiation-attenuated Plasmodium berghei sporozoites to elicit liver-resident and circulating memory T cells prior to boosting with a novel lipid nanoparticle mRNA vaccine encoding multiple CD8 T-cell epitopes from liver-stage proteins. We show that boosting primed mice with this mRNA vaccine engenders sterilizing immunity against sporozoite challenge by generating a robust liver-stage–specific CD8 T-cell response when administered intravascularly or intramuscularly. Thus, combining a single, dose-sparing attenuated sporozoite immunization with a multi-epitope translationally relevant mRNA vaccine can engender protective immunity against P. berghei sporozoite challenge via the generation of a potent circulating and resident memory liver CD8 T-cell response. Minimizing the number of attenuated sporozoite doses required to prime CD8 T cells with a full complement of liver-stage malaria–specific epitopes effectively mitigates some logistical challenges associated with attenuated sporozoite vaccination.

Förderung

  • National Institutes of Health

Zitieren

APA

Arumugam, S., Hassert, M., Franke-Fayard, B., & Harty, J. T. (2026). Robust CD8 T-cell response generated via attenuated Plasmodium sporozoite prime and multi-epitope mRNA vaccine boost. The Journal of Immunology, 215(11). https://doi.org/10.1093/jimmun/vkag314

Vancouver

Arumugam S, Hassert M, Franke-Fayard B, Harty JT. Robust CD8 T-cell response generated via attenuated Plasmodium sporozoite prime and multi-epitope mRNA vaccine boost. The Journal of Immunology. 2026;215(11). doi:10.1093/jimmun/vkag314

BibTeX
@article{Arumugam2026,
  author = {Arumugam, Sahaana and Hassert, Mariah and Franke-Fayard, Blandine and Harty, John T},
  title = {Robust CD8 T-cell response generated via attenuated Plasmodium sporozoite prime and multi-epitope mRNA vaccine boost},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {11},
  doi = {10.1093/jimmun/vkag314}
}
Kostenlos starten →